Treatment outcomes of sorafenib for first line or cytokinerefractory advanced renal cell carcinoma in Japanese patients

• UEDA Takeshi

  Division of Urology, Chiba Cancer Center

• IMAMURA Yusuke

  Department of Urology, Chiba University Graduate School of Medicine

• KOMARU Atsushi

  Division of Urology, Chiba Cancer Center

• FUKASAWA Satoshi

  Division of Urology, Chiba Cancer Center

• SAZUKA Tomokazu

  Division of Urology, Chiba Cancer Center

• SUYAMA Takahito

  Department of Urology, Chiba University Graduate School of Medicine

• NAYA Yukio

  Department of Urology, Chiba University Graduate School of Medicine

• NIHEI Naoki

  Department of Urology, Chiba University Graduate School of Medicine

• ICHIKAWA Tomohiko

  Department of Urology, Chiba University Graduate School of Medicine

• MARUOKA Masayuki

  Division of Urology, Chiba Cancer Center

Journal

• Int. J. Urol.

  Int. J. Urol. 17 (9), 811-815, 2010-09-01

Keywords

• adverse events
• metastasis
• renal cell carcinoma
• sorafenib

Details

• CRID: 1571980076179694336
• NII Article ID: 10027259996
• NII Book ID: AA11042471
• ISSN: 09198172
• Web Site: https://search.jamas.or.jp/link/ui/2011065227
• Text Lang: en
• Data Source:
  • CiNii Articles